Joydeep Roy - Passionate Pharma Marketer | Curiosity-led I Strategy-driven I Digitally empowered

From Idea to Execution, From Tracking to Validation

Hi I am Joydeep Roy, an Indian origin pharmaceutical professional currently based in Nairobi, Kenya. Apart from Kenya, have managed India, Srilanka, Cambodia, UAE at various role and capacities.

INDIAUAEKENYA · CURRENTPortrait of Joydeep RoySRI LANKACAMBODIA
01 / Biography

From Brand to generic, Doctor to paramedic, from meeting to meet-ups

Working in different markets has always widen my views & perpective

From the alleys of Kolkata to the boardrooms and roads of Nairobi, the thread that has guided my professional journey has been paying keen attention to the needs of healthcare markets.

After graduating from Jadavpur University with a bachelor’s degree in pharmaceutical technology, I started my career in pharmaceutical sales with Allergan India, a leader in ophthalmology. Over my sixteen-plus years in the industry, I have worked in product management, international marketing, training, sales-force effectiveness and new-product development. Currently based in Nairobi, Kenya, I work with Syner-Med Pharmaceuticals, looking after product management, training and digital initiatives.

Apart from India, I have also managed markets in the UAE, Sri Lanka and Cambodia in different roles and capacities.

16+Years of experience in sales, marketing, SFE, training and digital marketing
5 countriesIndia, Kenya, Cambodia, UAE and Sri Lanka
Ethical & OTCExperience across ethical and over-the-counter pharmaceutical businesses
Additional skillsWeb development, Tableau, Power BI and advanced Excel
02 / Education

Learning across science, management, digital and data.

A multidisciplinary academic journey that supports my work in pharmaceutical leadership and commercial decision-making.

Jadavpur University

Bachelor of Pharmacy (B.Pharm)

Completed

EMPI Business School

Post Graduate Diploma in Management (PGDM)

Completed

MICA — The School of Ideas

Post Graduate Certificate in Digital Marketing & Content Management

Completed

IIM Jammu

Executive Programme in Data Analytics

Completed
03 / Work Profile

Experience across the pharmaceutical commercial journey.

From field execution to business leadership, my roles connect customer understanding, brand strategy, capability building and digital growth.

Frontline Sales

Product Management

Product Training

Sales Force Effectiveness (SFE)

Digital Marketing

Online Platform & Ads Management

International Marketing

Business Management

04 / Companies

Organizations that shaped my professional journey.

Experience developed through association with pharmaceutical organizations across different roles, markets and stages of growth.

Allergan
Cipla
Sun Pharma
Alteus Biogenics
Mendine Pharmaceuticals
Palsons Derma
Bioplus
Syner-Med Pharmaceuticals
05 / Journey

Five market experiences. One clear focus today: Kenya.

Foundation

India: science, fieldwork and brand thinking

A B.Pharm education established the scientific base. Frontline sales and product roles in India then built a lasting respect for execution, customer insight and brand strategy.

Earlier reach

UAE, Sri Lanka and Cambodia: adapting across borders

Earlier business responsibility in these markets sharpened my approach: preserve strategic clarity, understand local context and never assume that one market’s answer automatically fits another.

Now

Kenya: leading close to the market

Based in Nairobi, I currently manage the Kenya business—keeping strategy and decision-making connected to local healthcare priorities, customers and field teams.

Focus

Turning insight into commercial excellence

My focus in Kenya is to strengthen brands, develop teams and use data, training and sales-force effectiveness to turn plans into consistent market action.

06 / Perspective

Applying cross-market experience to Kenya’s growth.

01Pharmaceutical brand strategyPositioning, launches and portfolio growth grounded in Kenya’s market realities
02Training & field effectivenessBuilding capable teams and turning knowledge into confident execution
03Commercial excellenceUsing insight, systems and performance discipline to improve outcomes
04Cross-market perspectiveKenya today · India, UAE, Sri Lanka and Cambodia earlier
Pharma Unscripted podcast logo
New podcast

Pharma Unscripted

Honest conversations with pharmaceutical and healthcare leaders—exploring the people, decisions and turning points behind meaningful careers.

Real people. Real journeys. Real lessons from Pharmaceuticals.Coming Soon
07 / Journal

Simple ideas from real work.

Easy-to-read thoughts on leadership, healthcare and business—based on what I have learned while working in Kenya, India, UAE, Sri Lanka and Cambodia.

Leadership & People · 3 min read

Kindness Is Not Weakness in Leadership

Accountability matters, but people never forget how a leader treated them during their hardest moment.

Read the story →
Healthcare · 3 min read

What the Field Knows Before the Dashboard

Sales teams, doctors and pharmacists often notice a change before it appears in a report.

Read the story →
AI & Pharma · 4 min read

AI Is Making Regulatory Work Easier

AI can make regulatory work faster and reduce effort—but every important answer still needs human validation.

Read the story →
08 / Healthcare Pulse

Three developments shaping healthcare now.

A concise, source-linked briefing on pharmaceutical research, public health and healthcare supply chains. Updated 29 October 2026.

Metabolic research

Retatrutide improves glucose control and weight loss versus Ozempic in Phase III trial

Lilly reported that investigational retatrutide reduced HbA1c by 2.2 percentage points versus 1.8 with Ozempic at 80 weeks. Higher-dose retatrutide produced 20.9% weight loss versus 9.4%; detailed results are forthcoming, and the medicine remains unapproved.

Why it matters: Provides comparative evidence for diabetes treatment development, although complete safety data and regulatory assessment remain essential.

Read at Reuters →
Tuberculosis research

WHO sets development targets for long-acting injectable TB medicines

WHO published target profiles to guide injectable medicines for tuberculosis prevention and treatment. Goals include single-injection preventive treatment and disease treatment delivered through three or fewer dosing encounters over no more than four months; these are development targets, rather than approved regimens.

Why it matters: Gives developers and TB programmes shared benchmarks for efficacy, safety, affordability and simpler delivery, potentially reducing adherence barriers.

Read at WHO →
Climate and health

Lancet Countdown highlights accelerating climate-related health risks

The 2026 Lancet Countdown reports increasing health harms from heat, drought and other climate hazards. WHO’s account links heat to an estimated 710,000 deaths globally in 2023, while highlighting health benefits from cleaner energy and stronger early-warning systems.

Why it matters: Reinforces the need for climate-resilient healthcare facilities, heat preparedness and surveillance to protect vulnerable populations.

Read at WHO →

Editorial summaries for general information only. Headlines link to the original sources; this section does not provide medical advice.

10 / Connect

Let’s continue the conversation.

Based in Nairobi and currently managing the Kenya business, with earlier experience across India, UAE, Sri Lanka and Cambodia. Choose a channel below to connect.

A working philosophy
“Every challenge is an invitation to think differently.”